Comparison of two approaches of sciatic nerve block via ultrasound guidance
- Conditions
- Fracture of lower leg, including ankle, (2) ICD-10 Condition: S92||Fracture of foot and toe, except ankle,
- Registration Number
- CTRI/2023/03/050911
- Lead Sponsor
- PGIMER Chandigarh
- Brief Summary
Popliteal sciatic nerveblock (PSNB) is commonly practised regional anaesthesia and analgesia techniquefor below-knee surgeries. It is used alone or combined with a femoral orsaphenous nerve block. The block can be performed blindly, guided by a nervestimulator or ultrasound. The blind landmark-based technique is not preferreddue to lower efficacy and higher complication rates.1 The use ofultrasound (USG) allows a real-time visualisation and delivery of themedication at the target site, improving precision, accuracy and safety. Thenerve block can be performed in the posterior, lateral and supine positions.Lateral and prone may pose challenges in morbidly obese, pregnant, hemodynamicallyunstable and/or spinal injury patients.2 In supineposition, the popliteal sciatic block can be performed by the posteriorapproach with out-of-plane needle entry, lateral or medial approach withlateral or medial in-plane needle entry respectively. The supine posteriorout-of-plane approach provides the advantage of patient comfort, less chance ofpuncturing the popliteal vessels and shorter needle path.3, 4
Recently, Mistry et alhave described an USG-guided CAPS (Crosswise approach to popliteal sciatic)block in a case series of 5 patients successfully with the advantage of betterpatient comfort as there is no need of patient positioning, flexion of hip andknees and external assistance.2
We aim to compare theUSG-guided posterior approach of popliteal sciatic block and CAPS block.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 52
Patients between age group 18-80 years undergoing below knee surgeries, ASA physical status I-III.
Patient refusal for nerve blocks, Allergy to amide local anaesthetic drugs, Chronic opioid therapy (>60 mg morphine daily or equivalent), Patients with thrombocytopenia/coagulopathy, on anti-coagulant and thrombolytic therapy, Morbid obesity (BMI>35 with obesity symptoms or BMI > 40), Neurological diseases, Local or systemic infection, Patients with psychiatric illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to perform the block (time interval from the contact of USG probe with the patient to the end of local anaesthetic injection)
- Secondary Outcome Measures
Name Time Method 3.Level of procedure related pain During performance of procedure 7.48 hour rescue analgesic consumption during 48 hr follow up 1. Block onset time time interval from the end of local anaesthetic injection to the achievement of complete sensory blockade of both saphenous and sciatic nerve 2.Number of needle passes During performance of procedure 4.Sciatic nerve visibility score and depth from skin During performance of procedure 5.Visual analog scale (VAS) scores immediate post-operation (T1), at 2 hours (T2), 4 hours (T3), 8 hours (T4), 12 hours (T5), 16 hours (T6), 24 hours (T7), and 48 hours (T8) 6.Time to first rescue analgesia during 48 hr follow up 8.Occurrence of any adverse events/complications during 48 hr follow up
Trial Locations
- Locations (1)
PGIMER Chandigarh
🇮🇳Chandigarh, CHANDIGARH, India
PGIMER Chandigarh🇮🇳Chandigarh, CHANDIGARH, IndiaDr Varun SinglaPrincipal investigator8427474087drvarunsinglapgi@gmail.com